Relx Plc (NYSE:RELX) Plans Semi-annual Dividend of $0.56

Relx Plc (NYSE:RELX) declared a semi-annual dividend on Tuesday, February 18th,Wall Street Journal reports. Shareholders of record on Friday, May 9th will be paid a dividend of 0.5586 per share by the technology company on Wednesday, June 25th. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, May 9th. This is a positive change from Relx’s previous semi-annual dividend of $0.23.

Relx has increased its dividend payment by an average of 4.5% per year over the last three years. Relx has a dividend payout ratio of 60.2% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Relx to earn $1.61 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 69.6%.

Relx Trading Down 0.4 %

Shares of NYSE RELX traded down $0.20 during trading on Tuesday, reaching $50.87. The company had a trading volume of 432,577 shares, compared to its average volume of 570,691. Relx has a 52 week low of $40.25 and a 52 week high of $51.99. The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63. The business’s 50 day moving average price is $47.89 and its 200-day moving average price is $47.19.

Analyst Upgrades and Downgrades

RELX has been the subject of a number of research analyst reports. StockNews.com raised shares of Relx from a “hold” rating to a “buy” rating in a research note on Friday. Redburn Atlantic initiated coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a “buy” rating for the company.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.